Key result
Corticosteroid therapy with prednisolone (50 mg/day) successfully controlled pleural and pericardial effusions in a patient with conventional therapy-resistant uremic pleuropericarditis.
Why the study?
Does prednisolone improve refractory uremic pleuropericarditis in a hemodialysis patient?
Case Report (n=1)
No
Does prednisolone improve refractory uremic pleuropericarditis in a hemodialysis patient?
Corticosteroid therapy may be useful for treating patients with conventional therapy-resistant uremic pleuropericarditis.
Corticosteroids may be considered for refractory uremic pleuropericarditis; hypothesis-generating from one case and needs prospective validation.
We report the case of a patient with uremic pleuropericarditis who showed a marked improvement following corticosteroid therapy. A 66-year-old man who had been on hemodialysis therapy for 13 years was admitted to our hospital presenting with increases in bilateral pleural effusions and pericardial effusion. Repeated thoracentesis showed hemorrhagic and exudative findings. Pleural and pericardial fluid cytologic examination, bacterial culture and acid-fast staining showed negative findings. Despite the administration of antibiotics and antituberculosis drugs, low-grade fever continued and C-reactive protein level remained high. A pleural biopsy revealed fibrinous pleuritis without infectious disease or malignancy. He was diagnosed as having uremic pleuropericarditis on the basis of the clinicopathological features, but had been unresponsive to conventional treatments including repeated thoracentesis and the continuance of hemodiafiltration using nafamostat mesylate. Ultimately, both pleural and pericardial effusions were controlled after the treatment with prednisolone at an initial dose of 50 mg per day. In conclusion, corticosteroid therapy seems to be useful for treating patients with conventional therapy-resistant uremic pleuropericarditis.
No takes yet. Share an insight, caveat, or question.
Iyoda et al. (2006) conducted a case report in Refractory uremic pleuropericarditis (n=1). Prednisolone vs. Conventional treatments was evaluated on Control of pleural and pericardial effusions. Corticosteroid therapy with prednisolone (50 mg/day) successfully controlled pleural and pericardial effusions in a patient with conventional therapy-resistant uremic pleuropericarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: